|
WO2021038975A1
|
|
Bifidobacterium spp. expressing and secreting diabody-type bsab
|
|
WO2018062225A1
|
|
Gene expression promotor for bifidobacterium genus bacteria
|
|
EP3228706A1
|
|
Coexpression plasmid
|
|
US2015290259A1
|
|
Therapeutic agent for ischemic diseases
|
|
US2017183667A1
|
|
Heterologous polypeptide expression cassette
|
|
KR20140046463A
|
|
Ischemic disease therapeutic agent
|
|
SG182446A1
|
|
Transformation plasmid
|
|
WO2010119936A1
|
|
Lactic acid bacterium mutated into obligatory anaerobe, method for constructing same, and expression vector functioning in obligatory anaerobic lactic acid bacterium
|
|
US2009264513A1
|
|
Expression vector
|
|
CN102747074A
|
|
Method of constructing gene transport support
|
|
CN101155911A
|
|
5-fluorouracil-resistant bacteria and method for production thereof
|
|
WO2006057289A1
|
|
Novel shuttle vector
|
